On May 14, 2021, the Centers for Medicare & Medicaid Services (CMS) released a display copy of a Final Rule (Final Rule) further delaying the effective date of the Medicare Coverage of Innovative Technology (MCIT) and...more
The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more
4/26/2021
/ Biden Administration ,
Critical Infrastructure Sectors ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part D ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda
On March 17, 2021, the Centers for Medicare & Medicaid Services (CMS) published a notice in the Federal Register delaying the effective date of the final rule titled, “Medicare Program; Medicare Coverage of Innovative...more
On November 20, 2020, the U.S. Centers for Medicare & Medicaid Services (CMS) issued an interim final rule (IFR) with comment period implementing a mandatory “Most Favored Nation” demonstration model (MFN Model) to test...more
11/24/2020
/ Biologics ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Drug Pricing ,
Health Insurance ,
Healthcare Reform ,
Interim Final Rules (IFR) ,
Medicare Part B ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Prescription Drug Coverage ,
Reimbursements
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time....more
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time. ...more
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time....more
The Centers for Disease Control and Prevention (CDC) urged organizers of large gatherings that involve shouting, chanting, or singing to “strongly encourage” attendees to use cloth face coverings to lower the risk of...more
6/15/2020
/ Airports ,
Amtrak ,
Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
FEMA ,
H-1B ,
Hiring & Firing ,
Immigration Procedures ,
Life Sciences ,
Personal Protective Equipment ,
Travel Ban ,
Trump Administration
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time....more
6/9/2020
/ AFMPS ,
Center for Drug Evaluation and Research (CDER) ,
CGMP ,
Coronavirus/COVID-19 ,
Enforcement Guidance ,
European Medicines Agency (EMA) ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Marketing Authorization Application ,
Medical Devices ,
Pharmaceutical Industry
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time.
...more
4/27/2020
/ Belgium ,
CARES Act ,
Coronavirus/COVID-19 ,
Federal Loans ,
Food and Drug Administration (FDA) ,
Judicial Proceedings ,
Life Sciences ,
Medical Devices ,
Medical Supplies ,
Paycheck Protection Program (PPP) ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Re-Opening Guidelines ,
Relief Measures ,
Supply Chain ,
Tax Relief